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Activation of MAPK overrides the
termination of myelin growth and replaces
Nrg1/ErbB3 signals during Schwann cell
development and myelination
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Max Delbrueck Center for Molecular Medicine, 13125 Berlin, Germany; 4Experimental Pharmacology and Oncology Berlin-Buch
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6Immune Regulation and Cancer, Max Delbrueck Center for Molecular Medicine, 13125 Berlin, Germany; 7Department of Cell
Biology and Genetics, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands; 8Signal Transduction, Invasion,
and Metastasis, Max Delbrueck Center for Molecular Medicine, 13125 Berlin, Germany
Myelination depends on the synthesis of large amounts of myelin transcripts and proteins and is controlled by
Nrg1/ErbB/Shp2 signaling. We developed a novel pulse labeling strategy based on stable isotope labeling with
amino acids in cell culture (SILAC) to measure the dynamics of myelin protein production in mice. We found that
protein synthesis is dampened in the maturing postnatal peripheral nervous system, and myelination then slows
down. Remarkably, sustained activation of MAPK signaling by expression of the Mek1DD allele in mice
overcomes the signals that end myelination, resulting in continuous myelin growth. MAPK activation leads to
minor changes in transcript levels but massively up-regulates protein production. Pharmacological interference in
vivo demonstrates that the effects of activated MAPK signaling on translation are mediated by mTOR-
independent mechanisms but in part also by mTOR-dependent mechanisms. Previous work demonstrated that
loss of ErbB3/Shp2 signaling impairs Schwann cell development and disrupts the myelination program. We found
that activated MAPK signaling strikingly compensates for the absence of ErbB3 or Shp2 during Schwann cell
development and myelination.
[Keywords: myelin; translational control; MAPK; pSILAC]
Supplemental material is available for this article.
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Myelination of axons is essential for the function of the
nervous system, and deficits in myelination cause devas-
tating disease (Suter and Scherer 2003; Quarles et al.
2006). Myelin sheaths electrically insulate axonal mem-
branes and allow fast propagation of nerve impulses by
saltatory conduction (Huxley and Stampfli 1949). The
thickness of myelin sheaths is believed to be optimized
for maximal conduction velocity (Smith and Koles 1970;
Waxman 1980). In the peripheral nervous system, Schwann
cells generate the myelin sheath. Only medium- and large-
caliber axons are myelinated, and myelin sheath thickness
is proportional to the axonal diameter (Donaldson and
Hoke 1905). Myelination is therefore closely controlled
and is accompanied by the production of large amounts of
myelin transcripts and proteins by the ensheathing glia.
The transcriptional control of myelination has been
intensely studied (Svaren and Meijer 2008), but due to
technical limitations, less is known about the trans-
lational control.
Post-transcriptional mechanisms play central roles in
gene expression. In fibroblasts, only;40% of the variability
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in protein levels can be attributed to mRNA levels
(Schwanha¨usser et al. 2011). Quantitative proteomic
analysis can be achieved by mass spectroscopy using
stable (i.e., nonradioactive) isotope labeling with amino
acids in cell culture (SILAC) and in mice (Kru¨ger et al.
2008; Cox and Mann 2011). In cultured cells, pulsed
SILAC (pSILAC) and dynamic SILAC techniques have
been used to quantify protein synthesis and degradation
(Selbach et al. 2008; Doherty et al. 2009; Schwanha¨usser
et al. 2011). Initiation of protein translation is highly
regulated and rate-limiting in protein biosynthesis. Rec-
ognition of the 59 mRNA cap structure and ribosomal
recruitment are critical in this regulation (Ma et al. 2005;
Kong and Lasko 2012). Cap recognition and ribosome
recruitment are accomplished by eukaryotic initiation
factor 4E (eIF4E) and eIF4E-binding proteins (4EBPs).
Growth factor signaling-dependent phosphorylation of
4EBPs and eIF4E enhance initiation of translation (Kong
and Lasko 2012). The mTOR complex 1 (mTORC1)
phosphorylates two key proteins in translational con-
trol: 4EBP1 and p70 S6 kinase (Hay and Sonenberg 2004;
Dowling et al. 2010; Song et al. 2012). In addition,
MAPK signaling also stimulates protein production, as
demonstrated in neurons and cancer cells (Kelleher et al.
2004; Topisirovic and Sonenberg 2011). MAPK signaling
activatesMnk1 and p90 ribosome S6 kinases (Rsk1-3) (see
Pyronnet et al. 1999; Roux et al. 2007). MAPK signaling
also phosphorylates the negative regulator of mTORC1
(Tsc2) and thus increases mTORC1 activity (Ma et al.
2005). Little is known about the control of protein trans-
lation during myelination.
In mice, myelination of peripheral nerves begins around
birth and continues into adulthood (Sherman et al. 2012).
Myelination is regulated by tyrosine kinase receptors,
integrins, and G-protein-coupled receptors and involves
complex changes in cell morphology and the generation
of large amounts ofmyelin (Nodari et al. 2007; Newbern and
Birchmeier 2010; Monk et al. 2011). Notably, Neuregulin-1
(Nrg1) provides an important neuronal signal that acti-
vates ErbB2 and ErbB3 tyrosine kinase receptors and
controls Schwann cell development and myelination
(Riethmacher et al. 1997; Garratt et al. 2000; Michailov
et al. 2004; Lyons et al. 2005; Taveggia et al. 2005). Nrg1
signaling influences the transcriptional myelination pro-
gram at the onset of myelination, during the myelination
process, and in myelin repair (Murphy et al. 1996; Lyons
et al. 2005; Taveggia et al. 2005; Fricker et al. 2013). Shp2/
MAPK, PI3K/Akt, PLC, and Rac1 signaling is activated
by Nrg1 and was implicated in myelination by genetic
analyses inmice (for review, see Newbern and Birchmeier
2010). In particular, mutation of the MAP kinases Erk1
and Erk2 or dampening of MAPK signaling after ablation
of the cytoplasmic tyrosine phosphatase Shp2 severely
disrupts Schwann cell development and myelination,
causing phenotypes similar to those observed in Nrg1 or
ErbB2 mutants (Grossmann et al. 2009; Newbern et al.
2011). mTOR mutation retards radial and longitudinal
growth of Schwann cells and results in the formation of
thin myelin accompanied by reduced phosphorylation of
themTOR substrates S6 and 4EBP1 (Sherman et al. 2012).
Myelination ceases in the maturing peripheral nervous
system, which was proposed to be controlled by a Dlg1-
mediated down-regulation of PI3K/Akt signaling in
Schwann cells (Cotter et al. 2010).
MAP kinase kinase 1 (Mek1) activates MAPK signaling
by phosphorylating Erk1 and Erk2. Here we report that
mild but sustained activation of MAPK signaling in
Schwann cells byMek1DD (a signaling-on allele) suffices
to replace ErbB3 and Shp2 during Schwann cell develop-
ment and myelination. Furthermore, sustained MAPK
signaling induced by Mek1DD results in continuous
myelin growth. We developed a novel in vivo pulse
labeling technique based on SILAC to directly quantify
protein production, which allowed us to assess trans-
lational changes during myelination. Our data demon-
strate that sustained MAPK signaling enhances protein
production and thus overcomes the attenuated trans-
lation that accompanies the maturation of the periph-
eral nervous system.
Results
Protein translation is markedly down-regulated during
maturation of peripheral nerves
Normal development of the peripheral nervous system is
characterized by rapid myelin growth in the postnatal
period, which then slows during maturation. In particu-
lar, radial myelin growth is fast during the first two
postnatal weeks in mice, reflected by a decrease in g-ratio
(axon diameter/myelinated fiber diameter) that reaches
a plateau around postnatal day 15 (P15). Subsequently,
myelin continues to grow at slower rates: first, radially,
mostly due to increasing axon diameter, and second,
longitudinally, due to an increase of animal size and
nerve length (see Fig. 1A for illustration; cf. Court et al.
2004; Sherman et al. 2012). We observed that maturation
is accompanied by a marked reduction of phosphor-
ylated Erk1/2 (p-Erk1/2) and p-Akt and a reduction of
overall levels of Erk1/2, Akt, and ErbB3 in peripheral
nerves (Fig. 1B). We also noted that various proteins
known to control protein translation, like eIF4E and S6,
were down-regulated in level and phosphorylation status
during maturation (Fig. 1B).
We therefore determined protein production during
maturation of peripheral nerves in an unbiased manner.
Recently developed pulsed metabolic labeling methods
can be used to measure protein synthesis and decay in
cultured cells (Selbach et al. 2008; Doherty et al. 2009).
This strategy was adapted to quantify changes in protein
synthesis in vivo (Fig. 1C). P30 mice were pulse-labeled
for 1 wk by feeding them chow containing heavy lysine
(Lys8). Since pulse labeling with solid diet is not possible
before weaning, we pulse-labeled P8 pups for 1 wk with
Lys6-labeled milk by providing Lys6-labeled foster
mothers. Ratios of heavy-labeled (Lys8 or Lys6) to light-
labeled (Lys0) peptides were measured separately in sam-
ples prepared from sciatic nerves of young and oldmice. To
allow a direct comparison and take into account differ-
ences in size and protein content of ‘‘old’’ and ‘‘young’’
nerves, additional ‘‘spike-in’’ experiments were performed
MAPK controls translation in myelination
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(see the Material and Methods). We observed a general
down-regulation of de novo production of overall protein
and particularly ribosomal and myelin proteins in the
‘‘old’’ nerves (Fig. 1D; Supplemental Table 1).
We next examined whether changes in myelin mRNA
levels can account for or contribute to the down-regulated
myelin production. Numbers of myelinating Schwann
cells in the sciatic nerves change little between P7 and
P42 (Court et al. 2004), but the length and diameter of
axons increase. To allow a direct comparison of mRNA
levels, we isolated entire nerves and used RNA spike-in
for normalization (cf. the Material and Methods and
Figure 1. Protein synthesis and Nrg1 signaling are down-regulated in maturing nerves. (A) Growth of myelinating Schwann cells at P8,
P15, and P30 is shown schematically. Axon diameter, myelin thickness, and internodal distance are scaled to display average changes
(cf. Court et al. 2004). (B) Western blot analysis investigating phosphorylation of signaling molecules in sciatic nerves of P8, P15, and
P30 mice. Tuj1 was used as loading control. (C) Outline of the pSILAC experiment performed to estimate protein synthesis in nerves of
‘‘old’’ and ‘‘young’’ mice. SILAC labeling was achieved by feeding Lys8-labeled chow or providing Lys6-labeled animals as foster
mothers. (D) Kernel density estimation plots showing the fold change of newly synthesized proteins in the nerves of mice at P30 (old)
versus P8 (young) as assessed by pSILAC and mass spectrometry; overall proteins or selected protein groups (ribosome, myelin) (cf.
Supplemental Table 1) are displayed. A shift to the left indicates decreased protein production in old mice. (E) qPCR analysis of myelin
gene expression from P0 to P62, normalized to an external control RNA from Caenorhabditis elegans (eif-3.D) and plotted as fold
change of the expression observed at P0. Error bars indicate SEM. (F) Correlation plot, comparison of fold changes in protein production,
and mRNA levels between old and young animals. Protein synthesis was assessed comparing P8 and P30 mice pulse-labeled for 1 wk.
RNA expression was compared between P11 and P33 by microarray analysis, normalized to ERCC RNA spike-in. We observed poor
correlation between changes in protein synthesis and steady-state mRNA levels.
Sheean et al.
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Loven et al. 2012). Quantitative PCR (qPCR) analyses
demonstrated that the expression of most myelin mRNAs
peaked around P30; i.e., were higher at P30 than at P8 (Fig.
1E). Thus, at the time when myelin mRNA levels peaked,
myelin protein synthesis was already down-regulated. To
compare changes in protein production and mRNA levels
in old and young nerves, we performed microarray expres-
sion analyses again using spike-in for normalization (Sup-
plemental Material; Supplemental Table 2). Changes in
protein production and transcript levels correlated poorly
when young and old nerves were compared (Pearson’s
correlation coefficient of +0.42) (Fig. 1F). Thus, our data
indicate that protein synthesis is down-regulated during
maturation of the peripheral nervous system. In particular,
myelin protein synthesis is reduced prior to the decrease in
the expression of the corresponding mRNAs.
Activation of Mek1 results in continuous myelin growth
Activation of MAPK and PI3K signaling was reported to
result in nerve hypermyelination (Narayanan et al. 2009;
Ishii et al. 2013). We next tested whether activation of
these signaling systems overcomes the signals that end
myelination. We expressed a gain-of-function Mek1 var-
iant (Mek1DD) in murine Schwann cells in vivo using
a Mek1DD transgene expressed upon Egr2Cre-mediated
deletion of a translational stop cassette (Egr2Cre;Mek1DD
mice are subsequently calledMek1DDmutants) (Supple-
mental Fig. S1A; cf. Voiculescu et al. 2000; Srinivasan
et al. 2009). In such mice, Cre is expressed in myelinating
Schwann cells starting around embryonic day 16 (E16).
Mek1 phosphorylates and activates Erk1/2, and, in accor-
dance, we observed enhanced Erk1/2 phosphorylation in
peripheral nerves of Mek1DD at P8, P15, and P30 com-
pared with control mice (Fig. 2A). However, Akt phos-
phorylation was affected little or not affected, although
overall Akt protein levels were elevated (Fig. 2A).
We analyzed myelination in Mek1DD mice, which
began prematurely with 5.8 6 3.1 and 12.4 6 5.8 myelin-
ated fibers per field at P0 in control and Mek1DD mice,
respectively. Furthermore, myelin sheaths were thicker
at P15 or P30, and myelin continued to grow radially
until P90, the latest stage at which the strain was analyzed
(Fig. 2B; Supplemental Fig. S1B). Thus, the g-ratio failed to
Figure 2. Activation of MAPK signaling
results in continuous myelin growth. (A)
Western blot analysis of total and phosphor-
ylated Erk1/2 and Akt in sciatic nerves of
control (c) andMek1DD (m) mice at P8, P15,
and P30. Neuronal tubulin (Tuj1) was used
as loading control. (B) Analysis of nerves
from control andMek1DDmice (P0–P90) by
electron microscopy. Representative axons
of similar diameters were false-colored. (C)
Mean g-ratios of fibers in sciatic nerves of
control and Mek1DD mice at the indicated
ages. (D) Binning analysis of myelin thick-
ness of groups of axons with the indicated
diameters; the nerves of control andMek1DD
mice at P30 were analyzed. (E) Distribution of
axon diameters in sciatic nerves of control
andMek1DDmice at P30 (n = 90 units total,
three mice per genotype). (F) Conduction
velocities of rapidly adapting mechanorecep-
tors (RAM), slowly adapting mechanorecep-
tors (SAM), D-hair mechanoreceptors (DH),
and Ad mechanonociceptors (AM) in saphe-
nous nerves at P30. (G) Conduction velocities
of motoneurons in ventral roots at P30. (H)
Western blot analysis of sciatic nerve extracts
from control and PI3KDA P15 animals; ex-
pression of PI3KDA enhanced Akt but not
Erk1/2 phosphorylation. Electron microscopy
analysis (I) and quantification of myelin thick-
ness (g-ratio) (J) of control and PI3KDA mice
(P15). (C,D,F,J) Two-tailed unpaired t-test. (G)
Two-way ANOVA (129–145 ventral root fibers
tested from L4–6, three mice per genotype).
(*) P < 0.05; (**) P < 0.01; (***) P < 0.001.
Error bars indicate SD (C–E,G,J) and SEM (F).
Bars: B,I, 2 mm.
MAPK controls translation in myelination
GENES & DEVELOPMENT 293
 Cold Spring Harbor Laboratory Press on February 5, 2014 - Published by genesdev.cshlp.orgDownloaded from 
level off inMek1DDmutants (Fig. 2C). We estimated that
the mean myelin area in peripheral nerves at P90 was
increased sixfold compared with controls. Increased my-
elin thickness was particularly pronounced in small-
diameter fibers (Fig. 2D), and, rarely, axons with a di-
ameter of <1 mm were myelinated inMek1DD nerves. In
contrast, control and Mek1DD mice showed no differ-
ence in axonal diameters (Fig. 2E), Schwann cell numbers
(358 6 22 and 416 6 45 nuclei per section; P = 0.17),
internodal distances (551.8 6 87.6 and 553.4 6 81.4 mm),
and the morphology of nodes of Ranvier and paranodes
(Supplemental Fig. S1C). Mek1DD expression was also
accompanied by a marked increase in the diameter of
sciatic nerves due to massive hypermyelination and re-
duced axonal packing (0.49 6 0.23 and 0.96 6 0.36 mm;
distance between nerve fibers in control and Mek1DD
mice, respectively) (Supplemental Fig. S1D,E). We con-
clude from these data that activation of MAPK signaling
perpetuates radial myelin growth and results in a pro-
nounced hypermyelination.
Myelin thickness is a determinant of conduction ve-
locity, but the effect of hypermyelination on conduction
velocities was not examined experimentally before. Mecha-
nosensory fibers are myelinated, and, in skin–nerve prepa-
rations, physiologically distinctmechanosensory fiber types
are distinguishable by firing properties and conduction
velocities (Milenkovic et al. 2008). We noted that D-hair
mechanoreceptors displayed significantly increased con-
duction velocity inMek1DD compared with control mice
at P30, but conduction velocities of other mechanosen-
sory fibers were unchanged (Fig. 2F). Conduction veloci-
ties of myelinated a-motoneurons were measured in
ventral root/sciatic nerve preparations and were similar
in control andMek1DDmice (Fig. 2G). We also examined
the effect of a constitutively active variant of PI3K
(PI3KDA) (cf. Srinivasan et al. 2009) on myelination
(Supplemental Fig. S1F). PI3KDA expression was initi-
ated by Egr2Cre-mediated recombination and was accom-
panied by very pronounced enhancement of Akt but not
Erk1/2 phosphorylation (Fig. 2H). Expression of PI3KDA
strongly interfered with myelination (Fig. 2I,J).
Continuous myelination in Mek1DD mice results
in pathological myelin structures
In addition to continuous myelin growth, we observed in
Mek1DD mice a number of myelin abnormalities. For
instance, myelin abundance at P60 compressed the axo-
plasm of some fibers (asterisks in Fig. 3A), andwe observed
aberrant paranodal myelin (tomaculi) and infolded myelin
loops (Fig. 3A). In addition, ‘‘onion bulb’’ structures were
observable (onion bulbs are signs of myelin degeneration
and regeneration) (arrowhead in Fig. 3A; cf. Suter and
Scherer 2003). Myelin abnormalities were present at
P30–P90 but not P15 (quantified in Fig. 3B), indicating
that they resulted from massive hypermyelination.
Furthermore, analysis of myelin ultrastructure showed
that stacking of myelin sheaths in compact myelin was
unaffected (space between myelin sheaths: 14.3 6 2.7
and 13.0 6 1.7 nm in control and Mek1DD mice,
Figure 3. Prolonged activation of MAPK signaling results in
the formation of aberrant myelin structures and in physiolog-
ical deficits. (A) Aberrant myelin structures in sciatic nerves of
Mek1DD mice at the indicated ages; asterisks indicate com-
pressed axons, the arrow indicates a myelinated axon with <1 mm
axonal diameter, and the arrowhead indicates an ‘‘onion bulb’’
structure. (B) Percentage of misfoldedmyelin structures identified
in control and Mek1DD mice at the indicated ages. (C) Visuali-
zation of Schmidt-Lanterman incisures using b-catenin staining
of teased nerve fibers. Nerves from Mek1DD (Mek1) and control
(con) animals are displayed. (D) Quantification of total axon
numbers and axons displaying a severe compression in saphe-
nous nerve. (E) Ratio of A/C compound action potential in
nerves of control and Mek1DD mice (five to six mice per
genotype) (left) and quantification of active units per axon
filament detected in conduction velocity tests (right). Bars, A,
2 mm; C, 50 mm. (B,D,E, left) Two-tailed unpaired t-test. (E, right)
Mann-Whitney U-test. (*) P < 0.05; (**) P < 0.01; (***) P < 0.001.
Error bars indicate SEM.
Sheean et al.
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respectively), but noncompact myelin structures were more
abundant (Schmidt-Lanterman incisures, indicated by ar-
rowheads in Fig. 3C).
The abnormal myelin structures observed at the late
stages in Mek1DD mice profoundly affected nerve phys-
iology. Conduction velocities in D-hair mechanorecep-
tors of Mek1DD mice were enhanced at P30, but such
differences were no longer observable after P60 (Supple-
mental Fig. S2A). Although it became difficult to find
mechanoreceptive fibers in the saphenous nerve of
Mek1DD mice after P60, myelinated axon numbers and
mechanoreceptive skin innervation appeared unaffected
(Fig. 3D; Supplemental Fig. S2B). The occurrence of com-
pressed axons (Fig. 3A,D) might result in a conduction
block. We therefore determined the ratio of compound
action potentials in myelinated A and nonmyelinated C
fibers (A/C fiber waves) and quantified numbers of active
mechanoreceptive units. A reduced ratio of A/C fiber
waves and reduced numbers of active mechanoreceptive
units were observed in Mek1DD mice after P60 (Fig. 3E),
indicating that many myelinated axons were not con-
ducting. Thus, the mild hypermyelination in young
Mek1DD mice results in increased conduction velocities
of D-hair mechanoreceptors, whereas pronounced hyper-
myelination and myelin abnormalities present at later
stages can block conduction.
Mek1DD expression enhances myelin protein
production but impinges little on myelin mRNA levels
We next determined the effect of Mek1DD on protein
production using pSILAC in vivo. Mek1DD and control
mice at P30 were pulse-labeled for 1 wk by feeding chow
containing medium–heavy lysine (Lys4) and heavy ly-
sine (Lys8), respectively. Subsequently, sciatic nerves were
combined and analyzed by mass spectrometry. The ratio
of Lys4 to Lys8 peak intensities in mass spectra reflects
differences in protein production in vivo (Supplemental
Fig. S3; see also the Supplemental Material). We indeed
observed higher amounts of labeled proteins in nerves of
Mek1DD mice than of control mice (Fig. 4A; see also
Supplemental Table 1). The production of ribosomal pro-
teins displayed a particularly strong increase, but myelin
proteins and enzymes involved in lipid biosynthesis were
also up-regulated. The increase in newly generated pro-
teins might be caused by increased synthesis or decreased
degradation. To estimate degradation, we performed a
SILAC chase experiment and observed that overall deg-
radation rates were not decreased but actually increased
inMek1DD compared with control nerves (Supplemental
Fig. S4A–C). Consistently, proteasome components were
also overproduced (Supplemental Fig. S4D). Thus, protein
synthesis was strongly increased in nerves of Mek1DD
mice, providing a molecular mechanism for the observed
hypermyelination.
Next, we compared protein production at an earlier
stage, when myelination is actively ongoing in normal
development. We pulse-labeled Mek1DD and control
pups at P8 with Lys6-labeled milk for 1 wk by providing
Lys6-labeled mice as foster mothers. The ratios of Lys6-
labeled to Lys0-labeled peptides were measured separately
in samples from Mek1DD and control mice, using addi-
tional ‘‘spike-in’’ experiments for quantification (cf. the
Supplemental Material). Again, newly synthesized pro-
teins were more abundant in Mek1DD compared with
control mice (Fig. 4B; see Supplemental Table 1).
We confirmed increased protein production by analyz-
ing steady-state protein levels at P30 using Western
blotting. Proteins whose production was strongly in-
creased were indeed present in higher quantities in nerves
of Mek1DD mutant mice (Fig. 4C), among them myelin
proteins (Pmp2 and Mag) and enzymes controlling lipid
biosynthesis (Slc27a4, Fasn, Acly, and Elovl7). MBP and
Mpz, the major components of peripheral myelin, dis-
played a 1.8-fold and 1.3-fold increase in steady-state
levels, respectively (Fig. 4C). We conclude that MAPK
activation in Schwann cells overcomes mechanisms that
end myelination by stimulating protein synthesis.
We also compared mRNA levels in control andMek1DD
sciatic nerves using microarray analysis at P8 and P30.
Changes in protein production and transcript levels
correlated poorly when control and mutant nerves were
compared (Fig. 4D,E). In particular, when all transcripts
were analyzed, Pearson’s correlation coefficients of r = +0.29
and 0.28 were found for P30 and P8, respectively. When
only transcripts whose expression changed by >1.2-fold
were included, the correlation improved at P30 (r = +0.51)
but not P8 (r = 0.34). Among the deregulated genes,
none encodes transcription factors known to control
myelination, and only few encode myelin proteins (see
Supplemental Tables 3–5). We reasoned that high
mRNA levels of myelin proteins might lead to probe
saturation in microarrays and thus to an underestima-
tion of changes in mRNA. Analysis of mRNA expres-
sion by qPCR demonstrated that transcript levels of
major components of peripheral myelin (e.g., Mpz and
MBP) were unaffected at P8, P15, or P30 (Fig. 4F). The
only significantly up-regulated myelin mRNA encodes
Pmp2, a member of the fatty acid-binding protein fam-
ily that represents a minor component of peripheral
myelin with no known function. Furthermore, five and
eight genes encoding enzymes in lipid biosynthesis were
up-regulated and down-regulated in microarray experi-
ments, respectively (Supplemental Table 3), and deregulated
expression of a subset was verified by qPCR (Supplemental
Fig. S5). Among highly up-regulated myelin proteins and
lipid biosynthesis enzymes, only Pmp2 and Elovl7 displayed
a corresponding up-regulation in mRNA levels (Fig. 4C,F;
Supplemental Table 3; Supplemental Fig. S5). In summary,
enhancedMAPK signaling does not broadly up-regulate the
myelination program on a transcriptional level but gener-
ally increases protein production.
Mek1DD signals via mTORC1-independent
and mTORC1-dependent mechanisms
MAPK signaling enhances protein translation in cultured
cells by activation of Mnk1/2, p90RSK1-3, and mTORC1,
which in turn phosphorylate eIF4E, S6, and 4EBP1
(Topisirovic and Sonenberg 2011). We therefore assessed
MAPK controls translation in myelination
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p-S6 levels by immunohistochemistry in Schwann cells
on teased nerve fibers from Mek1DD mice and found
a pronounced increase (Fig. 5A). Western blotting shows
that phosphorylation of eIF4E, S6, 4EBP1, andmTORwere
indeed strongly enhanced (Fig. 5B), and overall levels of
these proteins were also increased. Regulators of Akt
activity (i.e., Dlg1, PTEN, and p-PTEN) were unchanged,
and p-Akt levels were also unaffected, but overall Akt
protein was increased (Fig. 5B). The increased phosphory-
lation of eIF4E, S6, 4EBP1, and mTOR suggests mecha-
nisms for the increased protein production.
We next treated Mek1DD mutant mice with the
mTORC1 inhibitor everolimus (Schuurman et al. 1997)
to test towhat extentmTORC1 affects continuousmyelin
growth. Everolimus treatment started at P17 and extended
to P30. Thus, the inhibitor was provided during a period
in which overall g-ratios did not change in control mice,
whereas myelin growth continued in Mek1DD mutants
(see Fig. 2C). Everolimus did not affect myelin thickness
in control mice but dampened myelin growth in the
nerves of Mek1DD mutants (Fig. 5C,D) and completely
rescued the decreased axonal packing in Mek1DD mu-
tants (Fig. 5C,E). The eIF4E protein is a substrate of
Mnk1, which is directly activated by MAPK signaling
(Waskiewicz et al. 1997). eIF4E phosphorylation was not
affected by everolimus, but phosphorylation of mTOR and
Figure 4. SILAC pulse labeling reveals increased
protein synthesis in the nerves of Mek1DD mice.
(A,B) Kernel density estimation plots showing the
ratios of newly synthesized proteins in Egr2Cre;
Mek1DD versus control mice; overall proteins or
selected protein groups (ribosome, myelin, and lipid
synthesis enzymes) are displayed. The shift to the
right indicates an increased protein production in
Mek1DD mutants. Enzymes involved in lipid synthe-
sis were not detected when pups were analyzed. (C)
Western blot analysis of selected proteins previously
detected and quantified in SILAC pulse labeling ex-
periments. Tuj1 was used as loading control. (D,E)
Correlation plot comparison of fold changes in protein
production and mRNA levels in Mek1DD mutant
versus control nerves at P30 and P8; black dots indicate
mRNAs that are changed >1.2-fold, and dashed lines
indicate the average change in protein/mRNA levels.
(F) Quantification of transcripts of genes encoding
myelin proteins in P8, P15, and P30 sciatic nerves by
qPCR. Two-tailed paired t-test: (*) P < 0.05; (**) P <
0.01. Error bars indicate SD.
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the mTORC1 substrates S6 and 4EBP1 was strongly re-
duced (Fig. 5F). As observed in other cell types, everolimus
treatment increased p-Akt levels without affecting the
Akt regulators Dlg1 and PTEN (Dibble et al. 2009; Julien
et al. 2010). In summary, Mek1DD influences the protein
translation machinery by mTORC1-independent (eIF4E
phosphorylation) and mTORC1-dependent (S6 and 4EBP1
phosphorylation) mechanisms.
Expression of Mek1DD rescues deficits in Schwann cell
development and myelination caused by conditional
ablation of Shp2 or ErbB3
We previously reported that Shp2 mediates Nrg1/ErbB
signaling in Schwann cells (Grossmann et al. 2009). In
vivo, Egr2Cre-induced mutation of Shp2 results in pro-
nounced hypomyelination (Fig. 6A,B). We tested whether
Mek1DD expression can override the Shp2 dependency
in myelination and generated Egr2Cre;Shp2f/f;Mek1DD
compound mutant mice. In such mice, Egr2Cre activated
Mek1DD expression and ablated Shp2. Remarkably,
Mek1DD expression rescued the hypomyelination seen
in Egr2Cre;Shp2f/fmice, resulting at P15 in a g-ratio com-
parable with that observed in control mice, but myelin
growth continued, and axons were hypermyelinated
at P90 (Fig. 6A,B). Analysis of nerve extracts indicated
that expression of Mek1DD enhanced p-Erk1/2 but not
Dlg1, p-PTEN, and p-Akt in Shp2 mutant Schwann cells
(Fig. 6C). We also tested coexpression of a constitutively
active variant of PI3K in Shp2 mutant mice, but this did
not rescue the hypomyelination seen in Egr2Cre;Shp2f/f
mice (Fig. 6D,E). Instead, myelination deficits were
more pronounced than those observed in Egr2Cre;Shp2f/f
animals.
DhhCre drives Cre expression in Schwann cell pro-
genitors around E12 and thus introduces recombination
earlier than Egr2Cre. DhhCre-induced mutation of Shp2
therefore caused more severe phenotypes; i.e., reduced
Schwann cell numbers and disrupted entry into the
myelination program of remaining Schwann cells (Fig.
6F,G). Expression of Mek1DD in these ‘‘early’’ Shp2
mutants rescued Schwann cell numbers andmyelination,
but axons were hypermyelinated at P90 (Fig. 6F,G).
PI3KDA expression inDhhCre;Shp2f/fmice did not rescue
myelination (Supplemental Fig. S6A).
DhhCre-induced mutations of ErbB3 resulted in an
almost complete absence of Schwann cells (Fig. 6H). Re-
markably, expression ofMek1DD in these ErbB3mutants
rescued Schwann cell development, and Schwann cells
were able to myelinate (Fig. 6H,I). However, at P15 and
P90, 36.7% 6 23.7% and 17.8% 6 0.1% of axons with
diameters >1 mm were nonmyelinated, respectively,
compared with 3.5% 6 3.8% and 0.8% 6 0.0% in
control mice. At P15, the myelin of peripheral axons
of rescued ErbB3 mutants was thinner than in control
animals, but axons were hypermyelinated at P90 (Fig.
6I), indicating that myelin growth extended for pro-
longed periods. We did not observe myelination when
PI3KDA was expressed in mice carrying DhhCre-induced
mutations in ErbB3 (Supplemental Fig. S6B). We con-
clude that MAPK activation in Schwann cells com-
pensates for the ablation of ErbB3 or Shp2 and rescues
Nrg1-dependent Schwann cell development and mye-
lination.
To assess whether MAPK activation changed the
ensheathment fate of axons, we also compared unmyelin-
Figure 5. Pharmacological inhibition of mTORC1 rescues axo-
nal packing but not hypermyelination. (A) Staining of P30 teased
fibers using antibodies specific for phosphorylated ribosomal
protein S6 (p-S6), MBP, and DAPI. The specificity of the antibody
directed against p-S6 was verified by treating fibers with shrimp
alkaline phosphatase (SAP). (B) Western blot analysis of Erk and
eIF4E (top); mTOR and its substrates, S6 and 4EBP1 (middle);
PTEN, Dlg1, and their downstream effector, Akt (bottom). (C)
Electron microscopy images of P30 sciatic nerves of control and
Mek1DD mice treated with the mTORC1 inhibitor everolimus
or vehicle. Myelin thickness (g-ratio) (D) and axonal packing (E)
in sciatic nerves of control and Mek1DD mice treated with
everolimus or vehicle. (F) Western blot analysis indicates that
phosphorylation of mTOR and its substrates, S6 and 4EBP1, but
not of the Mnk1 substrate eIF4E, is abolished by everolimus
treatment. Bars: A, 10 mm; C, 5 mm. Two-tailed paired t-test: (*)
P < 0.05; (**) P < 0.01; (***) P < 0.001. Error bars indicate SD (D)
and SEM (E).
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ated axons in DhhCre;Mek1DD and control mice. We
rarely observed aberrantly myelinated small axons in the
mutants (diameter <1 mm). Remak bundles were present
and comparable, and the overall ratio of nonmyelinated to
myelinated axons was unchanged in DhhCre;Mek1DD
and control mice (Fig. 6J,K).
Figure 6. Expression of Mek1DD in Schwann cells compensates for the loss of Shp2 or ErbB3. Electron microscopy analysis at P15 (A)
and quantification of myelin thickness (g-ratio) of sciatic nerves (P15 and P90) (B) of Egr2Cre;Shp2f/f, Egr2Cre;Shp2f/f;Mek1DD and control
mice. (C) Western blot analysis of Erk1/2, Akt, PTEN, and Dlg1 in sciatic nerves of Egr2Cre;Shp2f/f and Egr2Cre;Shp2f/f;Mek1DDmice at P8.
Electronmicroscopy analysis at P15 (D) and quantification of myelin g-ratio (P15) (E) of sciatic nerves of Egr2Cre;Shp2f/f, Egr2Cre;Shp2f/f;PI3KDA
and control mice. Electron microscopy analysis at P15 (F) and g-ratio (P15 and P90) (G) of sciatic nerves of DhhCre;Shp2f/f,
DhhCre;Shp2f/f;Mek1DD, and control mice; the arrow in the inset points to Schwann cell cytoplasm surrounding an unmyelinated axon.
Electron microscopy analysis at P15 (H) and g-ratio (P15 and P90) (I) of sciatic nerves of DhhCre;ErbB3f/f, DhhCre;ErbB3f/f;Mek1DD, and
control mice; the arrow in the inset points toward axonal membranes not surrounded by Schwann cell cytoplasm. Note that expression of
the Mek1DD allele rescues myelination and Schwann cell deficits observed in Shp2 and ErbB3 mutant mice. Electron microscopy
analysis (J) and quantification (K) of nonmyelinated/myelinated axons in DhhCre;Mek1DD and control mice at P15. The arrow in the left
panel indicates a myelinated axon with <1 mm axonal diameter in the DhhCre;Mek1DD mutant. The middle and right panels show
Remak bundles. Bars, 2 mm. Two-tailed paired t-test: (*) P < 0.05; (**) P < 0.01; (***) P < 0.001. Error bars indicate SEM.
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Shp2 mutation reduces overall protein synthesis
and myelin protein production
We previously reported transcriptional changes in Schwann
cells after mutation of Shp2 using Egr2Cre (Grossmann et al.
2009). Microarray analysis showed that many genes were
deregulated in Egr2Cre;Shp2f/fmutant nerves (Supplemen-
tal Tables 6–8). Most of these were down-regulated; for
instance, 63 genes encoding enzymes of lipid biosynthesis
(Supplemental Table 6). Furthermore, qPCR demon-
strated that mRNAs of major myelin proteins were
down-regulated (Fig. 7A). Thus, the loss of Shp2 affects
myelination on a transcriptional level. We examined total
protein and myelin protein production in Egr2Cre;Shp2f/f
mutant nerves using pSILAC at P30 and P8. This demon-
strated that not only transcription but also overall protein
translation and, in particular, production ofmyelin protein
and lipid synthesis enzymes were down-regulated in Shp2
mutant nerves (Fig. 7B,C). To assess this further, we
compared changes in mRNA and protein levels (Fig.
7D,E). Analysis of all transcripts indicated a poor correla-
tion between changes in transcript and protein levels at
P30 (Pearson’s correlation coefficient r = +0.3). However,
when only transcripts that were changed by >1.2-fold were
included, the correlation improved (r = +0.44). At P8,
changes in transcript and protein levels correlated well
regardless of whether all transcripts (r = +0.71) or only the
subset of transcripts that were changed (r = +0.75) were
included in the analysis. Thus, mutation of Shp2 interferes
with myelination on a transcriptional and translational
level.
We next tested whether genetic activation of MAPK sig-
naling rescued deficits in protein production and transcript
Figure 7. Mek1DD rescues transcriptional and trans-
lational deficits of Shp2 mutant Schwann cells. (A)
Quantification of transcripts encoding myelin proteins
by qPCR at P15. Changes in the levels of several myelin
gene transcripts were underestimated in microarray
experiments, possibly due to probe saturation. Down-
regulation of myelin gene mRNA in Egr2Cre;Shp2f/f
mutant nerves was largely rescued by Mek1DD expres-
sion. (B,C) Kernel density estimation plots showing the
ratios of newly synthesized proteins in the nerves of
Egr2Cre;Shp2f/f mutant versus control mice at P30 and
P8 as assessed by pSILAC and mass spectrometry;
overall proteins and selected protein groups (ribosome,
myelin, and enzymes involved in lipid synthesis) are
displayed. A shift to the left indicates decreased protein
production in Egr2Cre;Shp2f/f mutants. Enzymes in-
volved in lipid synthesis were not detected when pups
were analyzed. (D,E) Correlation plot of fold changes in
protein production and mRNA levels in Egr2Cre;Shp2f/f
mutant versus control nerves at P30 and P8; black dots
indicate mRNAs that are changed >1.2-fold, and dashed
lines indicate the average change in protein/mRNA lev-
els. (F) Western blot analysis of selected proteins identified
as down-regulated in the nerves of Egr2Cre;Shp2f/f mu-
tants (Shp2) using mass spectrometry. Additional expres-
sion of Mek1DD in Egr2Cre;Shp2f/f mutants rescued the
levels of these proteins (Shp2/Mek1). Two-tailed paired
t-test: (*) P < 0.05. Error bars indicate SD.
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levels caused by the Shp2 mutation using qPCR and
Western blot analysis. Many changes that we identified
by global mRNA and protein analyses were compensated
for (Fig. 7A,F). In particular, down-regulation of myelin
proteins Mpz and MBP or lipid biosynthesis factors such
as Elovl7, Fasn, Slc27a4, and Acly were rescued. Hence,
activation of MAPK signaling largely rescues transcrip-
tional as well as translational Schwann cell deficits caused
by loss of Shp2.
Discussion
Here we used newly developed pSILAC methods in mice
to demonstrate that synthesis of overall proteins and of
myelin proteins massively decreases in Schwann cells
during maturation of the peripheral nervous system.
However, the termination of myelin growth can be over-
come by stimulating protein synthesis through sustained
MAPK activation (Mek1DD expression). This results in
continuous myelin growth and enhances the efficacy of
myelin protein production. It is known that Nrg1/ErbB/
Shp2 signals provide important cues that drive Schwann
cell development and myelination. We show here that
sustained MAPK activation compensates for the ablation
of ErbB3 or Shp2 and thus replaces Nrg1/ErbB signals.
Translational control of myelination
We used novel pSILAC labeling procedures to record
changes in protein production during maturation of the
peripheral nervous system in mice. Similar strategies
were previously used in cultured cells (Selbach et al.
2008; Doherty et al. 2009). We employed the new strategy
to compare protein synthesis and degradation during
myelination, but our techniques should also be applicable
in other tissue types. In our study, a broad protein repertoire
could be quantified. We found that enhanced protein
synthesis following activation of MAPK signaling was
generally not associated with concordant changes in the
expression of the corresponding mRNAs, emphasizing
that information about mRNA levels does not suffice to
understand the process of myelination.
It was estimated that during myelination, the mem-
brane area of Schwann cells increases several thousand-
fold, a process accompanied by a huge increase in myelin
protein. Our data show that during postnatal develop-
ment of peripheral myelin, protein production rates are
strongly regulated. Translational control of myelination
in the peripheral nervous system has received little
attention, but it is interesting to note that mutations in
components of the initiation factor complex eIF2B result
in delayed myelination and aberrant myelin maintenance
in the central nervous systems of humans and mice
(Leegwater et al. 2001; Geva et al. 2010).
We show that sustained MAPK activation byMek1DD
expression in Schwann cells leads to enhanced protein
synthesis and provide evidence that this is mediated by
mTORC1-independent mechanisms but in part also
by mTORC1-dependent mechanisms. We assessed this
by pharmacological inhibition of mTORC1 between P17
and P30; i.e., during a period in which the g-ratio changes
little in control mice, although myelin continued to grow
in Mek1DD mutants. In Mek1DD mice, myelin growth
was slowed down but not fully abrogated by mTORC1
inhibition, but the reduced axonal packing was com-
pletely rescued. MAPK signaling phosphorylates the neg-
ative regulator of mTORC1 (Tsc2) and can thus increase
mTORC1 activity (Ma et al. 2005). Phosphorylation of
eIF4E could participate in the MAPK-dependent but
mTORC1-independent mechanism regulating myelin
growth (Pyronnet et al. 1999). Previous work showed that
mTORmutation retards radial and longitudinal Schwann
cell growth (Sherman et al. 2012). Activation of mTOR by
PTEN mutation does not result in a general hypermyeli-
nation. Instead, a small subpopulation of axons is hyper-
myelinated, and tomaculi are formed (Goebbels et al.
2012). We also employed here a constitutively active
variant of PI3K (PI3KDA) that strongly enhanced Akt
activity. Expression of PI3KDA interfered with myelina-
tion, indicating that a tight regulation of PI3K/Akt activity
is required. In summary, we suggest that the effects of
Mek1DD on translation are mediated by mTORC1-
dependent and mTORC1-independent mechanisms (see
Supplemental Fig. S7 for a summary of MAPK signaling
and translational control).
Schwann cell dependence on Nrg1/ErbB signals
is abrogated by MAPK activation
Nrg1 and the ErbB2/3 receptors provide pivotal signals for
Schwann cell development and myelination that are
mediated by the tyrosine phosphatase Shp2 (Grossmann
et al. 2009). We found that activation of MAPK signaling
by the Mek1DD allele releases Schwann cells from their
natural ErbB3/Shp2 dependence. Nrg1/ErbB signals elicit
different cellular responses at distinct developmental
stages; for example, ErbB3 deficiency during early de-
velopment results in nerves that are virtually devoid of
Schwann cells, a consequence of impaired precursor pro-
liferation and migration (Riethmacher et al. 1997; Lyons
et al. 2005). Furthermore, Nrg1/ErbB signaling controls
the initiation of Egr2 expression and, consequently, the
onset of myelination (Murphy et al. 1996; Lyons et al.
2005; Taveggia et al. 2005). Likewise, mutation of Shp2 or
ErbB2 after onset of myelination or heterozygous Nrg1
mutations indicate that Nrg1/ErbB signaling controls
myelin growth (Garratt et al. 2000; Michailov et al. 2004;
Grossmann et al. 2009). Interestingly, activation of MAPK
signaling by the Mek1DD allele largely rescues prolifera-
tion, migration, and myelination deficits and thus suffices
to replaceNrg1/ErbB/Shp2 signals in Schwann cells during
early development and myelination.
Previous work indicates that Nrg1/ErbB signaling reg-
ulates transcriptional aspects of the myelination program
(Lyons et al. 2005; Taveggia et al. 2005). Also, after myelin-
ation has commenced, ablation of Shp2 or ErbB2 decreased
transcript levels of many myelination genes (Grossmann
et al. 2009; this study), and these transcriptional deficits can
again be rescued by expression of Mek1DD. Nevertheless,
we found that sustained mild activation of MAPK in
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wild-type Schwann cells has little effect on transcrip-
tion. We therefore propose that saturating levels of MAPK
signals in transcriptional and translational control are
distinct. The transcriptional myelination program seems
fully stimulated by MAPK under normal conditions;
i.e., a further increase of MAPK activity does not en-
hance it significantly. However, when the MAPK signal
falls below a threshold, transcription of myelin genes
decreases (e.g., Shp2 mutants), and this is again stimu-
lated by increased MAPK activity (e.g., Shp2;Mek1DD
mutants). In comparison, translational efficacy is not
maximally stimulated byMAPKunder normal conditions.
Thus, translation responds more dynamically to the
strength of MAPK signal: Further MAPK activation
enhances translation, whereas reduction of the MAPK
signal impairs it. Interestingly, it was noted previously
that cellular responses to MAPK activation can depend
on the strength and duration of the activating signal
(Dikic et al. 1994; Katz et al. 2007).
Nrg1 and the ErbB2/3 receptors activate many down-
stream signaling cascades, such as Shp2/MAPK, PI3K/
Akt, PLC/Calcineurin, or Rac1, and extensive work im-
plicated these in various steps of Schwann cell develop-
ment such as axonal sorting, Schwann cell morphogenesis,
and transcriptional control of myelination (Nodari et al.
2007; Grossmann et al. 2009; Kao et al. 2009; Newbern
et al. 2011; Goebbels et al. 2012). The fact that the
Mek1DD allele can replace Nrg1/ErbB3/Shp2 signaling
indicates that many of these signaling cascades are
regulated via MAPK, although this might not necessarily
be achieved by direct mechanisms.
Myelin thickness and the end of myelination
Myelin thickness and Schwann cell length (i.e., the in-
ternodal distance) are crucial parameters that determine
conduction velocity. Furthermore, myelin thickness is
highly conserved in evolution and is believed to be
optimized for maximal nerve conduction (Huxley and
Stampfli 1949; Smith and Koles 1970; Waxman 1980; Wu
et al. 2012). However, our analysis shows that one partic-
ular myelinated fiber type, D-hair mechanoreceptors,
actually conducts faster when hypermyelinated. The con-
duction velocity of D-hair receptors is therefore not
maximized. It is possible that temporal coding of mech-
anosensory information might be advantageous; for in-
stance, to allow the central nervous system to distin-
guish stimuli mediated by D-hair and other types of
mechanoreceptors.
In mice, peripheral myelination occurs very rapidly
during the first postnatal weeks. Whenmyelin reaches its
optimal thickness and length, myelin growth slows down
but continues at a pace sufficient for myelin mainte-
nance. Cell-autonomous and paracrine mechanisms that
end myelination have been discussed in recent studies
(Cotter et al. 2010; Macklin 2010). We observed markedly
reduced levels of ErbB3, p-Erk1/2, and p-Akt protein and
reduced protein synthesis rates during maturation. Since
MAPK activation by the Mek1DD allele overcomes the
controlmechanisms that terminatemyelination, activation
of MAPK might provide a tool to stimulate myelination
and particularly allow Schwann cells to re-enter active
myelination in pathological settings.
Materials and methods
Animals
ROSA26-STOP-Mek1DD, ROSA26-STOP-PI3KDA, Egr2Cre,
DhhCre, and Shp2f strains were described (Garratt et al. 2000;
Voiculescu et al. 2000; Jaegle et al. 2003; Grossmann et al. 2009;
Srinivasan et al. 2009). The ErbB3f allele is described in the
Supplemental Material and in Supplemental Figure S8. Controls
in rescue experiments were Cre-negative littermates, and con-
trols in the loss-of-function analyses were Cre-positive and Cre-
negative Shp2f/+ and ErbB3f/+ littermates.
Control and Egr2Cre;Mek1DD mutant littermates were in-
jected intraperitoneally between P17 and P30 5 d a week for 2 wk
with everolimus (5 mg/kg body weight; Sigma) dissolved in
DMSO/PBS (5/95 [v/v]) or corresponding vehicle. Nerves from
everolimus-treated mice were isolated within 2 h after the last
treatment.
Immunohistology and g-ratio analysis
Immunohistology and electron microscopy were performed as
described (Grossmann et al. 2009; Wende et al. 2012). Mean
g-ratios were calculated with a correction including nonmyelin-
ated axons >1 mm diameter. The standard deviation between
values in individual animals was taken as error (see the Supple-
mental Material).
Microarray and qPCR analysis
Total RNA from sciatic nerves was labeled and hybridized to
Affymetrix Mouse Genechip 1.0 or 2.0 ST arrays as specified by
the manufacturer. Microarray data were analyzed using Partek
Genomics suite 6.5 and 6.6. For the comparison of mRNA
levels in sciatic nerves, we used wild-type mice aged P11 or P33,
the midpoints of the pSILAC experiments. We supplemented
each P11 or P33 sample with equal amounts of ERCC RNA
Spike-in Control Mix1 (Ambion), which was further used for
normalization of microarray data to obtain expression levels
per nerve (Loven et al. 2012). For qPCR analysis, cDNA was
synthetized using SuperScript III (Invitrogen) and analyzed
using Absolute qPCR SYBR Green mix (AbGene) on a Bio-Rad
C1000 Thermal Cycler (see the Supplemental Material). For the
comparison of mRNA levels in sciatic nerves of P0, P8, P15,
P30, and P62 wild-type mice, we used additional spike-in of
Caenorhabditis elegans RNA for normalization (see the Sup-
plemental Material).
In vivo pSILAC labeling and mass spectrometry
Custom-made chow containing Lys4 or Lys8 (D4-L-lysine and
13C4,
15N4-L-lysine; Silantes no. 230914520 and 230984640) was
used to pulse-label P30 animals. P8 mice cannot be labeled with
solid food; they were therefore labeled via mother’s milk pro-
vided by completely Lys6-labeled (13C6-lysine; Silantes no.
230924530) foster mothers (Kru¨ger et al. 2008). Sciatic nerves
were isolated and analyzed by mass spectrometry using a Q
Exactive mass spectrometer (Thermo Scientific). For analysis,
non-normalized MaxQuant ratios were used, and proteins with
at least three ratio counts were included (see the Supplemental
Material).
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